Study comparing the efficacy of dexmedetomidine as an adjuvant for post mastectomy analgesia

A Prospective Randomised Double Blinded Comparative Study Comparing the Efficacy of Dexmedetomidine as an adjuvant to Ropivacaine versus Ropivacaine alone in the Ultrasound Guided Deep Serratus Anterior Plane Block for Post Mastectomy Analgesia - nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059958

Enrollment

Registered

2023-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Ultrasound Guided Deep Serratus Anterior Plane Block with Dexmedetomidine as an adjuvant to Ropivacaine.: Dexmeditomidine is added as an adjuvant to Ropivacaine for Deep serratus anteri

Eligibility

Inclusion criteria

Inclusion criteria: American society of Anaesthesiologists(ASA) 1-3

Exclusion criteria

Exclusion criteria: Refusal to participate in the study Age ASA class 4 & 5 Known coagulation disorders Allergy to Local anaesthetics Unconscious or mentally incompetent Pregnancy & Hemodynamic instability

Design outcomes

Primary

Measure	Time frame
Time to initial onset of pain ( VAS score greater than or equal to 4) and time to first rescue analgesia Quality of recovery after anaesthesia using the Qor 15 questionnaireTimepoint: 0 mins 30 mins 1 hr 2 hr 4 hr 8 hr 12 hr 16 hr 20 hr 24 hr	—

Secondary

Measure	Time frame
number of rescue analgesics usedTimepoint: over a period of 24 hours	—

Countries

India

Contacts

Public ContactIlancheran J

Sri Ramachandra Institute of Higher Education and Research

reetharun@gmail.com9840529863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026